These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33107659)

  • 1. Disease Progression in Patients with Parkin-Related Parkinson's Disease in a Longitudinal Cohort.
    Sun YM; Yu HL; Zhou XY; Xiong WX; Luo SS; Chen C; Liu FT; Zhao J; Tang YL; Liang XN; Yang YJ; Shen B; Shen Y; Yu WB; Ding ZT; An Y; Wu JJ; Wang J
    Mov Disord; 2021 Feb; 36(2):442-448. PubMed ID: 33107659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-motor Symptoms in Parkinson's Disease Patients with Parkin Mutations: More Depression and Less Executive Dysfunction.
    Song J; Shen B; Yang YJ; Liu FT; Zhao J; Tang YL; Chen C; Ding ZT; An Y; Wu JJ; Sun YM; Wang J
    J Mol Neurosci; 2020 Feb; 70(2):246-253. PubMed ID: 31927768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early-onset Parkinson's disease.
    Ton ND; Thuan ND; Thuong MTH; Ngoc TTB; Nhung VP; Hoa NTT; Nam NH; Dung HT; Son ND; Ba NV; Bac ND; Tai TN; Dung LTK; Hung NT; Duong NT; Ha NH; Hai NV
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1463. PubMed ID: 32856414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin is the most common causative gene in a cohort of mainland Chinese patients with sporadic early-onset Parkinson's disease.
    Jiang Y; Yu M; Chen J; Zhou H; Sun W; Sun Y; Li F; Wei L; Pinkhardt EH; Zhang L; Yuan Y; Wang Z
    Brain Behav; 2020 Sep; 10(9):e01765. PubMed ID: 32677319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin mutations and phenotypic features in Czech patients with early-onset Parkinson's disease.
    Fiala O; Pospisilova L; Prochazkova J; Matejckova M; Martasek P; Novakova L; Roth J; Ruzicka E
    Neuro Endocrinol Lett; 2010; 31(2):187-92. PubMed ID: 20424582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
    Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
    Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Event-related potential changes due to early-onset Parkinson's disease in parkin (PARK2) gene mutation carriers and non-carriers.
    Uslu A; Ergen M; Demirci H; Lohmann E; Hanagasi H; Demiralp T
    Clin Neurophysiol; 2020 Jul; 131(7):1444-1452. PubMed ID: 32388155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel compound heterozygous of PARKIN causes early-onset Parkinson's disease.
    Yu LH; Peng GP; Yuan Y; Liu XY; Ji F; Li Y; He FP; Luo BY; Ke Q
    Neurosci Lett; 2021 Jan; 744():135597. PubMed ID: 33373675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.
    Caccappolo E; Alcalay RN; Mejia-Santana H; Tang MX; Rakitin B; Rosado L; Louis ED; Comella CL; Colcher A; Jennings D; Nance MA; Bressman S; Scott WK; Tanner CM; Mickel SF; Andrews HF; Waters C; Fahn S; Cote LJ; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Siderowf AD; Ross BM; Verbitsky M; Kisselev S; Ottman R; Clark LN; Marder KS
    J Int Neuropsychol Soc; 2011 Jan; 17(1):91-100. PubMed ID: 21092386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARKIN, PINK1, and DJ1 analysis in early-onset Parkinson's disease in Ireland.
    Olszewska DA; McCarthy A; Soto-Beasley AI; Walton RL; Ross OA; Lynch T
    Ir J Med Sci; 2022 Apr; 191(2):901-907. PubMed ID: 33751372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between depression and parkin genotype: the CORE-PD study.
    Srivastava A; Tang MX; Mejia-Santana H; Rosado L; Louis ED; Caccappolo E; Comella C; Colcher A; Siderowf A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Alcalay RN; Ross B; Orbe Reilly M; Rezak M; Novak K; Friedman JH; Pfeiffer RD; Marsh L; Hiner B; Merle D; Ottman R; Clark LN; Marder K
    Parkinsonism Relat Disord; 2011 Dec; 17(10):740-4. PubMed ID: 21856206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.
    Kim HJ; Kim HJ; Lee JY; Yun JY; Kim SY; Park SS; Jeon BS
    J Neurol; 2011 Dec; 258(12):2260-7. PubMed ID: 21625934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.
    Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG;
    Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic analysis of Chinese patients with early-onset Parkinson' s disease.
    Liu Q; Jiang B; Zou M; Wan HJ; Yu ZW; Wang J; Xu CC; Lin SN; Zheng KM; Xiao NA; Bi M; Li JP
    Neurosci Lett; 2022 Nov; 790():136880. PubMed ID: 36150414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella CL; Nance MA; Bressman SB; Scott WK; Tanner CM; Mickel SF; Waters CH; Fahn S; Cote LJ; Frucht SJ; Ford B; Rezak M; Novak KE; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Payami H; Molho E; Factor SA; Nutt JG; Serrano C; Arroyo M; Ottman R; Pauciulo MW; Nichols WC; Clark LN; Marder KS
    JAMA Neurol; 2014 Jan; 71(1):62-7. PubMed ID: 24190026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families.
    Deng H; Le W; Shahed J; Xie W; Jankovic J
    Neurosci Lett; 2008 Jan; 430(1):18-22. PubMed ID: 18068301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Study of Early Onset Parkinson's Disease in Cyprus.
    Abu Manneh R; Chairta PP; Mitsi E; Loizidou MA; Georgiou AN; Christou YP; Pantzaris M; Zamba-Papanicolaou E; Hadjisavvas A
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression in the LRRK2-Asssociated Parkinson Disease Population.
    Saunders-Pullman R; Mirelman A; Alcalay RN; Wang C; Ortega RA; Raymond D; Mejia-Santana H; Orbe-Reilly M; Johannes BA; Thaler A; Ozelius L; Orr-Urtreger A; Marder KS; Giladi N; Bressman SB;
    JAMA Neurol; 2018 Mar; 75(3):312-319. PubMed ID: 29309488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
    Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F
    Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.